← SynDRA
LURBINECTEDIN
SynDRA canonical compound SYN0039662 — structure-anchored drug synonym record
| Clinical phase | Phase 3 |
|---|
| Approval status | Approved · Rx |
|---|
| Mechanism of action | DNA binding agent |
|---|
Mechanisms of action (all sources)
Drug classes
- Alkylating Activity
- Alkylating Drug
ATC classes
- L01X · OTHER ANTINEOPLASTIC AGENTS
Cross-references
Synonyms
- zepzelca
- PM01183
- PM-01183
- LY-01017
- PM-1183
- tryptamicidin
- zepsyre
- Lurbinectedine
- Lurbinectedina
- Tryptamicidin
- PM1183
- Zepsyre
- Zepzelca
- UNII-2CN60TN6ZS
- 2CN60TN6ZS
- Lurbinectedin [INN]
- SCHEMBL16152477
- DTXSID30198065
- DB12674
- CS-6323
- HY-16293
- J3.652.626B
- PM 01183
- lurbinectedina
- lurbinectedine
- lurbinectedinum
- RefChem:56744
- DTXCID60120556
- Lurbinectedin?
- LURBINECTEDIN [MI]
- Lurbinectedin [USAN:INN]
- LURBINECTEDIN [USAN]
- LURBINECTEDIN [WHO-DD]
- orb1308109
- SCHEMBL29362379
- GTPL10681
- WLZ4516
- LURBINECTEDIN [ORANGE BOOK]
Reported adverse events
- Abdominal pain
- Chest pain
- Constipation
- Cough
- Extravasation
- Fatigue
- Headache
- Hepatotoxicity
- Infection
- Musculoskeletal pain
- Myelosuppression
- Nausea
Look up LURBINECTEDIN in the interactive SynDRA portal →